A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Zai Lab LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 88,300 shares of ZLAB stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,300
Previous 28,214 212.97%
Holding current value
$2.36 Million
Previous $488,000 336.68%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$16.25 - $24.14 $976,397 - $1.45 Million
60,086 Added 212.97%
88,300 $2.13 Million
Q2 2024

Aug 09, 2024

BUY
$13.72 - $21.55 $185,412 - $291,226
13,514 Added 91.93%
28,214 $488,000
Q1 2024

May 13, 2024

BUY
$15.95 - $26.8 $60,610 - $101,840
3,800 Added 34.86%
14,700 $235,000
Q4 2023

Feb 13, 2024

BUY
$22.97 - $30.58 $13,782 - $18,348
600 Added 5.83%
10,900 $298,000
Q3 2023

Nov 14, 2023

SELL
$22.72 - $31.49 $54,528 - $75,576
-2,400 Reduced 18.9%
10,300 $250,000
Q2 2023

Aug 11, 2023

SELL
$25.3 - $39.67 $609,730 - $956,047
-24,100 Reduced 65.49%
12,700 $352,000
Q1 2023

May 12, 2023

SELL
$30.21 - $48.1 $2.23 Million - $3.55 Million
-73,900 Reduced 66.76%
36,800 $1.22 Million
Q4 2022

Feb 13, 2023

BUY
$22.28 - $38.71 $1.83 Million - $3.17 Million
82,000 Added 285.71%
110,700 $3.4 Million
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $3.26 Million - $4.93 Million
-95,414 Reduced 76.88%
28,700 $982,000
Q2 2022

Aug 12, 2022

BUY
$23.14 - $49.68 $2.87 Million - $6.17 Million
124,114 New
124,114 $4.3 Million
Q1 2022

May 13, 2022

SELL
$27.77 - $64.4 $9.59 Million - $22.2 Million
-345,200 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$54.9 - $105.21 $4.86 Million - $9.31 Million
88,500 Added 34.48%
345,200 $21.7 Million
Q3 2021

Nov 12, 2021

BUY
$105.0 - $178.37 $27 Million - $45.8 Million
256,700 New
256,700 $27.1 Million
Q2 2021

Aug 13, 2021

SELL
$125.11 - $180.0 $10.1 Million - $14.6 Million
-81,100 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$126.27 - $191.71 $10.2 Million - $15.5 Million
81,100 New
81,100 $10.8 Million
Q2 2020

Aug 13, 2020

SELL
$48.82 - $82.53 $8.93 Million - $15.1 Million
-182,831 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$39.1 - $62.9 $5.04 Million - $8.1 Million
-128,800 Reduced 41.33%
182,831 $9.41 Million
Q4 2019

Feb 13, 2020

SELL
$29.79 - $43.06 $1.7 Million - $2.45 Million
-57,000 Reduced 15.46%
311,631 $13 Million
Q3 2019

Nov 13, 2019

SELL
$30.47 - $37.65 $606,353 - $749,235
-19,900 Reduced 5.12%
368,631 $11.9 Million
Q2 2019

Aug 12, 2019

BUY
$25.73 - $35.79 $5.68 Million - $7.9 Million
220,731 Added 131.54%
388,531 $13.5 Million
Q1 2019

May 14, 2019

BUY
$21.71 - $31.54 $3.17 Million - $4.6 Million
145,800 Added 662.73%
167,800 $4.95 Million
Q4 2018

Feb 13, 2019

BUY
$14.95 - $24.72 $328,900 - $543,840
22,000 New
22,000 $511,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.62B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.